Clinical Trial Update: HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598

View source ↗

Summary

This update describes the investigation of HER-2 mutations in tumor samples from patients with advanced non-small cell lung cancer who were treated on the ECOG-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lung Cancer | Status: COMPLETED